Advanced Magnetics seeks expanded Feridex use:
This article was originally published in Clinica
Executive Summary
Advanced Magnetics has submitted a supplemental new drug application (sNDA) to the US FDA to expand the indications of its Feridex IV MRI contrast agent. The product is currently cleared to aid in the detection of liver lesions, but the Cambridge, Massachusetts company seeks approval to use the agent for characterising the lesions as benign or metastatic. In addition, the company would like a more convenient, rapid infusion, dosing regimen.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.